# Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT

> **NCT01672801** · NA · COMPLETED · sponsor: **Boston IVF** · enrollment: 18 (actual)

## Conditions studied

- Unexplained Infertility
- Polycystic Ovarian Syndrome
- Anovulatory

## Interventions

- **DRUG:** Placebo
- **DRUG:** Nimodipine

## Key facts

- **NCT ID:** NCT01672801
- **Lead sponsor:** Boston IVF
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01672801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01672801, "Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01672801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*